Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara Shochet

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|August 6, 2019
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trialThomas Easterling, Shuchita Mundle, Hillary Bracken, et al.
Fertility and Sterility|August 27, 2011
In vitro fertilization patients support a single blastocyst transfer policySarina Martini, Bradley J Van Voorhis, Barbara J Stegmann, et al.
Reproductive Health Matters|February 23, 2015
Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico CityPatricio Sanhueza Smith, Melanie Peña, Ilana G Dzuba, et al.
Contraception|March 23, 2004
Side effects of the Yuzpe regimen of emergency contraception and two modificationsTara Shochet, Kelly Blanchard, Helen King, et al.
BMC Women'S Health|August 1, 2016
Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in TunisiaRasha Dabash, Tara Shochet, Selma Hajri, et al.
Obstetrics and Gynecology|August 24, 2011
Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trialNguyen Thi Nhu Ngoc, Tara Shochet, Sheila Raghavan, et al.
Contraception|September 7, 2019
Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal<sup>.</sup>Jennifer Blum, Chanda Karki, Anand Tamang, et al.
BMC Pregnancy and Childbirth|November 16, 2012
Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countriesTara Shochet, Ayisha Diop, Alioune Gaye, et al.
Contraception|July 30, 2021
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.SHolly A Anger, Elizabeth G Raymond, Melissa Grant, et al.
BMC Women'S Health|August 24, 2017
Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends after assisted reproductionTara Shochet, Ioanna A Comstock, Nguyen Thi Nhu Ngoc, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|August 6, 2019
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trialThomas Easterling, Shuchita Mundle, Hillary Bracken, et al.
Fertility and Sterility|August 27, 2011
In vitro fertilization patients support a single blastocyst transfer policySarina Martini, Bradley J Van Voorhis, Barbara J Stegmann, et al.
Reproductive Health Matters|February 23, 2015
Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico CityPatricio Sanhueza Smith, Melanie Peña, Ilana G Dzuba, et al.
Contraception|March 23, 2004
Side effects of the Yuzpe regimen of emergency contraception and two modificationsTara Shochet, Kelly Blanchard, Helen King, et al.
BMC Women'S Health|August 1, 2016
Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in TunisiaRasha Dabash, Tara Shochet, Selma Hajri, et al.
Obstetrics and Gynecology|August 24, 2011
Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trialNguyen Thi Nhu Ngoc, Tara Shochet, Sheila Raghavan, et al.
Contraception|September 7, 2019
Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal<sup>.</sup>Jennifer Blum, Chanda Karki, Anand Tamang, et al.
BMC Pregnancy and Childbirth|November 16, 2012
Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countriesTara Shochet, Ayisha Diop, Alioune Gaye, et al.
Contraception|July 30, 2021
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.SHolly A Anger, Elizabeth G Raymond, Melissa Grant, et al.
BMC Women'S Health|August 24, 2017
Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends after assisted reproductionTara Shochet, Ioanna A Comstock, Nguyen Thi Nhu Ngoc, et al.
Pageof 5